TherapeuticsMD Revenue and Competitors

Claim your profile

Miami, FL USA

Location

$508.6M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • TherapeuticsMD's estimated annual revenue is currently $90.8M per year.(i)
  • TherapeuticsMD received $85.0M in venture funding in August 2018.
  • TherapeuticsMD's estimated revenue per employee is $307,966
  • TherapeuticsMD's total funding is $508.6M.
  • TherapeuticsMD's current valuation is $144.5M. (January 2022)

Employee Data

  • TherapeuticsMD has 295 Employees.(i)
  • TherapeuticsMD grew their employee count by -14% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$21.9M109N/AN/AN/A
#2
$2.4M297%N/AN/A
#3
$233.6M1162N/AN/AN/A
#4
$3M369%N/AN/A
#5
$4.8M58-5%N/AN/A
#6
$5.3M640%N/AN/A
#7
$211.7M1050-2%N/AN/A
#8
$19.5M977%N/AN/A
#9
$2.9M3584%N/AN/A
#10
$4.6M5617%N/AN/A

TherapeuticsMD, Inc. is an innovative pharmaceutical company exclusively committed to advancing the health of women and championing awareness of their health care issues. We create products to address the unique changes and challenges women experience through every stage of their lives. With momentum fueled by the needs of our customers, we combine entrepreneurial spirit and clinical expertise to develop innovative solutions designed to go beyond what is presently available. This includes a variety of therapies in our pipeline, along with prescription prenatal vitamins under the vitaMedMD® and BocaGreenMD® brands. See our community guidelines: https://www.therapeuticsmd.com/social-media-community-guidelines

keywords:Biotechnology,Cleantech,Healthcare,Pharmaceuticals,Wind Power

$508.6M

Total Funding

295

Number of Employees

$90.8M

Revenue (est)

-14%

Employee Growth %

$144.5M

Valuation

N/A

Accelerator

TherapeuticsMD News

2022-04-17 - TherapeuticsMD Inc. stock falls Friday, underperforms market MarketWatch

TherapeuticsMD Inc. stock falls Friday, underperforms market MarketWatch

2022-04-13 - TherapeuticsMD Completes the Divestiture of vitaCare Prescription ... Business Wire

TherapeuticsMD Completes the Divestiture of vitaCare Prescription ... Business Wire

2019-09-03 - Can TherapeuticsMD, Inc. (TXMD) Keep Its Momentum?

Russell Angus C., Director, added 10,000 shares of TherapeuticsMD, Inc. (TXMD) to its portfolio at the rate of $2.77 per share valuing $27,700 ...

2019-09-03 - Here's Why TherapeuticsMD Jumped 34% in August

Shares of TherapeuticsMD (NASDAQ: TXMD) jumped 34% in August, according to data provided by S&P Global Market Intelligence, after the ...

2019-08-20 - TherapeuticsMD stock slides 6% after SEC charges company ...

TherapeuticsMD Inc. shares TXMD, +3.61% slid about 6% Tuesday, after the Securities and Exchange Commission charged the company with ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$32.5M2950%N/A
#2
$89.1M300-5%N/A
#3
$45.5M30311%N/A
#4
$48M3203%N/A
#5
$108.3M3216%N/A

TherapeuticsMD Funding

DateAmountRoundLead InvestorsReference
2012-09-27$8.5MUndisclosedArticle
2013-03-18$57.5MUndisclosedJefferies LLCArticle
2013-10-11$33.0MUndisclosedArticle
2014-03-24$73.4MUndisclosedArticle
2014-07-31$40.0MUndisclosedArticle
2015-02-12$UndisclosedUndisclosedCowen and CompanyArticle
2017-09-26$70.1MUndisclosedJ.P. MorganArticle
2018-08-01$85.0MUndisclosedGoldman Sachs & Co. LLCArticle